March 2014 Mental Health

Although research has associated migraines with restless legs syndrome, the results of a new study suggest that migraines are not more common in patients with the condition.

According to the results of a recent study, symptoms associated with restless legs syndrome change depending on the season and are most severe during the summer.

New research finds that patients with restless legs syndrome often feel compelled to eat late at night, and that the habit may lead to an increase in body mass index.

The results of a new study found that higher levels of vitamin D were associated with improved cognition and mood in patients with Parkinson's disease.

Exposure to common pesticides may increase the risk for Parkinson's disease, the results of a recent study suggest.

Deep brain stimulation may help patients with Parkinson's disease improve their driving, according to a study conducted in Germany.

A recent study found that women with higher body mass indices and larger waist circumferences may be at an increased risk for hearing loss.

Although many Americans may believe that a healthy diet is an expensive one, a recent study found that the cost difference between healthy and unhealthy foods is small.

Case studies involving penicillin allergy and rhinosinusitis.

Our latest round-up of barely legible scripts.

Pharmacists can learn to apply counseling strategies to help address common patient questions to achieve optimal symptom relief in allergic rhinitis.

Pharmacists can learn about educating patients on the risk of stroke in atrial fibrillation, monitoring anticoagulation therapy, and participating in disease management opportunities.

Although attention-deficit/hyperactivity disorder is a long-term condition, it can be managed with proper treatment.

Our columnist sees a bright future for abuse-resistant formulations.

A pharmacist is told that a board of pharmacy hearing may result in the revocation of his license to practice. May he challenge the decision in court by alleging that he was not alerted to the possibility of permanent revocation?

NACDS anticipates another successful conference in Boston this August.

A proposed rule changing drug labeling permissions would add $4 billion to the nation's annual health care costs, finds a study sponsored by the Generic Pharmaceutical Association.

Our round-up of new generic products.

A molecular geneticist has set out to crowdfund his dream of producing a less time-consuming method of analyzing and sequencing DNA.

Pharmacists can emphasize to patients that anxiety is a real disease with effective treatments.

Genetics, the environment, and hormones may play a role in lupus.

Changing antiepileptic drugs might improve seizure control and/or reduce adverse effects, but the risks of a switch must be considered.

Our round-up of the latest OTC products.

The influence of mental illness on adherence among patients who should be taking warfarin is not well understood.

Our round-up of the latest Rx products.

Trokendi XR (topiramate) is an antiepileptic drug FDA approved for treating partial-onset seizures and primary, generalized tonic-clonic seizures in patients 10 years and older and for adjunctive use in children as young as 6 years with Lennox-Gastaut syndrome or partial-onset seizures.

Doping violates the spirit of sports and is dangerous.

This new series highlights pharmacists who have gone the "extra mile" to help others.

In 2013, many new medications and new indications were approved.